Month 3 on Semaglutide: What 12 Weeks of Treatment Looks Like
Three full months on semaglutide. Twelve injections, two titrations, and a body that knows what the weekly rhythm feels like. Month 3 is the first real review point — the place where you take stock and decide what the next phase looks like.
Month 3 lands at the end of the third titration cycle on the standard Wegovy schedule. By this point, most users have finished the 0.25mg, 0.5mg, and 1.0mg blocks, with the next step — 1.7mg — scheduled to begin shortly. Some prescribers hold longer at 1.0mg if tolerability is the priority; others move on schedule. Both paths are routine.
The STEP 1 weekly weight-loss curve, replicated in multiple cohorts since, shows mean cumulative loss of roughly 6% of starting body weight by week 12 on the titration schedule. Individual results vary widely — some people are well above that, others below — but 6% is the benchmark clinical practice often uses to confirm early response. Below about 5% at 12 weeks, prescribers typically reassess.
Appetite Suppression
Reliable, often profound suppression by the end of the 1.0mg phase. The next dose step tends to deepen it further, though returns diminish at the top of the range.
Mean cumulative loss by month 3 in STEP cohorts was around 6%, with wide variation depending on starting weight, response, and titration pace.
The Month 3 journey
The Month 3 Timeline
Weeks 9-10
Steady on 1.0mg
Side effects are usually minimal in this stretch. Appetite suppression is at a working level, and most users describe it as the first time the medication feels routine rather than novel.
Weeks 11-12
Three-Month Review
Pull together weight, measurements, side effect notes, lab work if scheduled, and habit shifts. Most prescribers do a formal review here — bring data, not just impressions.
End of Month 3
Decision Point
Titrate to 1.7mg, hold at 1.0mg, or step back if tolerability has been an issue. All three are legitimate. Confirm the plan before your next pen.
What changes by Month 3
The body has adapted. Initial nausea, fatigue, and reflux that defined weeks one through four are usually background noise or gone. Appetite suppression that felt novel in month one is the new baseline — meals are smaller because they have to be, and "food noise" between meals has quieted for most users.
Body composition is shifting too. Twelve weeks of reduced intake usually pulls fat preferentially, but some lean mass loss is expected if protein and resistance training are not part of the picture. Many prescribers start emphasizing this at the three-month mark: aim for around 1.2–1.6g of protein per kilogram of body weight per day, and incorporate resistance work at least twice a week.
The mental shift is the part most users underestimate going in. By month 3, the loop of "want food → eat food → think about food" has loosened. Some describe it as quiet, others as boring — both are normal. What used to take willpower now happens by default.
Navigating Symptoms
Constipation, mild reflux, and occasional fatigue are the most common lingering effects at month 3. None are typically severe at this stage. New or persistent severe abdominal pain warrants medical evaluation.
What other users say
What Users Report
“Three months in, I'm down about 7% and the bigger thing is I trust the process. I'm not white-knuckling anything. The medication does its part and I do mine.”
— Lila S.
“My doctor and I agreed to hold at 1.0mg for another month before going to 1.7mg. The pace felt right and there was no reason to rush.”
— Anthony R.
Looking ahead
Month 3 to month 6 is where the trajectory becomes the story. The titration phase is over, the next dose step is in play, and the work shifts from "starting" to "sustaining." Continue to the Month 6 guide for what the halfway mark of a full year looks like, or visit the resources hub for the broader journey map.